Skip to main content

Table 1 Baseline characteristics of Study Participants (N = 10)

From: A human model of inflammatory cardio-metabolic dysfunction; a double blind placebo-controlled crossover trial

  

Mean (SD)

Age (years)

 

22.7 (3.8)

 

Males

20.4 (3.2)

 

Females

25.0 (2.9)

BMI (kg/m 2 )

 

24.0 (2.3)

Waist Circumference (m)

 

0.85 (0.06)

TNF-α (pg/mL)

 

0.9 (0.4)

IL-6 (pg/mL)

 

1.5 (0.8)

CRP (mg/L)

 

1.2 (1.4)

 

Males

0.5 (0.2)

 

Females

1.8 (1.7)

Systolic Blood Pressure (mmHg)

 

115.5 (7.2)

Diastolic Blood Pressure (mmHg)

 

69.1 (3.3)

Heart rate (bpm)

 

58.9 (9.9)

Temperature (K)

 

309.3 (255.4)

Total Cholesterol (mmol/L)

 

4.42 (0.83)

HDL-C (mmol/L)

 

1.54 (0.33)

 

Males

1.25 (0.09)

 

Females

1.83 (0.19)

Triglycerides (mmol/L)

 

0.89 (0.34)

 

Males

0.76 (0.25)

 

Females

1.03 (0.39)

LDL-C (mmol/L)

 

2.22 (0.56)

*FSIGTT-insulin sensitivity index (SI, x 10 -4 (μU/ml) -1 ·min -1 )

 

3.4 (1.1) ^

†HOMA-IR insulin resistance index

 

10.4 (2.77)

(AIRg, μU·ml -1 ·min)

 

400.5 (152.6) ^

†HOMA-B beta-cell function index

 

1555.6 (931.3)

  1. *FSIGTT = Frequently Sampled Intravenous Glucose Tolerance Test. † HOMA = Homeostatic Model Assessment ^ In N = 5 subjects.